Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen
- 1 May 1995
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 126 (5) , 716-721
- https://doi.org/10.1016/s0022-3476(95)70398-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A 7-year follow-up of newborns vaccinated against hepatitis BVaccine, 1993
- Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: Immunogenicity and anamnestic responsesHepatology, 1993
- A 9-Year Follow-Up Study of the Immunogenicity and Long-Term Efficacy of Plasma-Derived Hepatitis B Vaccine in High-Risk Chinese NeonatesClinical Infectious Diseases, 1993
- Combined active-passive immunization against the hepatitis B virusThe Pediatric Infectious Disease Journal, 1993
- Vaccination aginst chronic viral carriage in The GambiaThe Lancet, 1991
- Five-year follow-up of vaccination against hepatitis B virus in newborns vaccinated with a reduced number of dosesVaccine, 1991
- HEPATITIS B VACCINATION IN NEWBORN BABIESThe Lancet, 1988
- Persistence of specific antibodies after hepatitis B vaccinationJournal of Hepatology, 1988
- Hepatitis B vaccine in infants from an endemic area: Long‐term anti‐HBs persistence and revaccinationJournal of Medical Virology, 1987
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual MenNew England Journal of Medicine, 1986